Cara Therapeutics

(NASDAQ: CARA)
Health Care  |  Pharmaceuticals
8.37 -0.57 -6.38%
Stock Price | May 18, 2022, 4 p.m.
1 Follower
Bid: 8.37
Ask: 16.17
Prev. Close: 8.94
52 Week Low: 7.4
52 Week High: 18.93
PE Ratio:
Dividend Yield: %

Company Summary

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Read more Read less

Recently Viewed Tickers

6 years ago
6 years ago
6 years ago

Premium Livestox, Jul 23 2015... Big payoffs

31 Comments
6 years ago

Premium Livestox, Jul 16 2015.. Lots and lots of stocks

27 Comments
6 years ago

Premium Livestox, Jul 2 2015

5 Comments
6 years ago

Premium Livestox, Jun 24 2015... GWPH's "momentum" of truth

28 Comments
6 years ago
7 years ago